Rachel Ostroff

6.1k total citations
49 papers, 1.6k citations indexed

About

Rachel Ostroff is a scholar working on Molecular Biology, Genetics and Biomedical Engineering. According to data from OpenAlex, Rachel Ostroff has authored 49 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 9 papers in Genetics and 9 papers in Biomedical Engineering. Recurrent topics in Rachel Ostroff's work include Advanced biosensing and bioanalysis techniques (10 papers), Biosensors and Analytical Detection (9 papers) and Advanced Proteomics Techniques and Applications (8 papers). Rachel Ostroff is often cited by papers focused on Advanced biosensing and bioanalysis techniques (10 papers), Biosensors and Analytical Detection (9 papers) and Advanced Proteomics Techniques and Applications (8 papers). Rachel Ostroff collaborates with scholars based in United States, United Kingdom and Germany. Rachel Ostroff's co-authors include Michael L. Vasil, Adriana I. Vasil, Stephen A. Williams, Edward N. Brody, Bengt Wretlind, Larry Gold, Dom Zichi, Jeffrey J. Walker, Michael R. Mehan and Harvey I. Pass and has published in prestigious journals such as Circulation, Nature Medicine and Nature Communications.

In The Last Decade

Rachel Ostroff

48 papers receiving 1.5k citations

Peers

Rachel Ostroff
Comparison fields: 5 of 118
  • Molecular Biology 910
  • Pulmonary and Respiratory Medicine 218
  • Genetics 203
  • Epidemiology 189
  • Biomedical Engineering 189
James D. Chang United States
Gary Woodnutt United States
Erin H. Seeley United States
David H. Goetz United States
Kazuyuki Sogawa Japan
Takanori Sakaguchi Japan
Jochen Metzger Germany
Edward Tarelli United Kingdom
Jie Lu China
Hayato Miyachi Japan
James D. Chang United States View profile →
Citations per field, relative to Rachel Ostroff
Rachel Ostroff · 1×
Citations per year, relative to Rachel Ostroff
Rachel Ostroff · 1×

Countries citing papers authored by Rachel Ostroff

Since Specialization
Citations

This map shows the geographic impact of Rachel Ostroff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Ostroff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Ostroff more than expected).

Fields of papers citing papers by Rachel Ostroff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Ostroff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Ostroff. The network helps show where Rachel Ostroff may publish in the future.

Co-authorship network of co-authors of Rachel Ostroff

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Ostroff. A scholar is included among the top collaborators of Rachel Ostroff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Ostroff. Rachel Ostroff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 HFrEF subphenotypes based on 4210 repeatedly measured circulating proteins are driven by different biological mechanisms EBioMedicine Folkert W. Asselbergs, Magdaléna Harakaľová et al. 16
2 Machine learning–based biomarker profile derived from 4210 serially measured proteins predicts clinical outcome of patients with heart failure European Heart Journal - Digital Health Anja J. Rueten‐Budde, K. Martijn Akkerhuis et al. 6
3 Defining the serum proteomic signature of hepatic steatosis, inflammation, ballooning and fibrosis in non-alcoholic fatty liver disease Journal of Hepatology Arun J. Sanyal, Stephen A. Williams et al. 48
4 Proteomic signatures for identification of impaired glucose tolerance Nature Medicine Julia Carrasco-Zanini, Maik Pietzner et al. 26
5 Author Correction: Genetic architecture of host proteins involved in SARS-CoV-2 infection Nature Communications Maik Pietzner, Eleanor Wheeler et al. 0
6 Coronary Artery Disease and Type 2 Diabetes: A Proteomic Study Diabetes Care Giulia Ferrannini, Maria Laura Manca et al. 44
7 Genetic architecture of host proteins involved in SARS-CoV-2 infection Nature Communications Maik Pietzner, Eleanor Wheeler et al. 69
8 Discovery and Validation of a Six-Marker Serum Protein Signature for the Diagnosis of Active Pulmonary Tuberculosis Journal of Clinical Microbiology Mary Ann De Groote, David G. Sterling et al. 65
9 Improving Assessment of Drug Safety Through Proteomics Circulation Stephen A. Williams, Robert Kirk DeLisle et al. 25
10 Abstract 17082: Translation From Highly Multiplexed Biomarker Discovery to a Targeted Protein Panel to Stratify Cardiovascular Risk in Patients With Coronary Heart Disease Circulation Robert Kirk DeLisle, Peter Ganz et al. 1
11 Development of a Protein Biomarker Panel to Detect Non–Small-Cell Lung Cancer in Korea Clinical Lung Cancer Young Ju Jung, Evaldas Katilius et al. 35
12 Phospholipase C: Molecular Biology and Contribution to the Pathogenesis of Pseudomonas aeruginosa1 Antibiotics and chemotherapy/Antibiotica et chemotherapia Michael L. Vasil, Rachel Ostroff et al. 5
13 Protein Signature of Lung Cancer Tissues PLoS ONE Michael R. Mehan, Deborah Ayers et al. 70
14 Detection of resectable pancreatic cancer with SOMAmer proteomic technology. Journal of Clinical Oncology Randall E. Brand, Malte Buchholz et al. 1
15 Highly Multiplexed Proteomic Platform for Biomarker Discovery, Diagnostics, and Therapeutics Advances in experimental medicine and biology Michael R. Mehan, Rachel Ostroff et al. 55
16 Unlocking Biomarker Discovery: Large Scale Application of Aptamer Proteomic Technology for Early Detection of Lung Cancer PLoS ONE Rachel Ostroff, William L. Bigbee et al. 163
17 The stability of the circulating human proteome to variations in sample collection and handling procedures measured with an aptamer-based proteomics array Journal of Proteomics Rachel Ostroff, Trudi Foreman et al. 58
18 RAPID DETECTION OF GROUP A STREPTOCOCCAL ANTIGEN WITH A NEW OPTICAL IMMUNOASSAY The Pediatric Infectious Disease Journal Rachel Ostroff et al. 14
19 Effect of specimen storage, antibiotics, and feminine hygiene products on the detection of Group B Streptococcus by culture and the STREP B OIA test Diagnostic Microbiology and Infectious Disease Rachel Ostroff et al. 26
20 Cell cycle regulation of induced mutagenesis in yeast Mutation research. Fundamental and molecular mechanisms of mutagenesis Rachel Ostroff, Robert A. Sclafani 21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026